All articles tagged with #income investing
MPLX and Fidus Investment are rated Buy for durable, high‑yield income portfolios: MPLX offers a 7.4% yield with about 12.5% expected annual distribution growth underpinned by fee-based contracts and energy projects, while FDUS yields 11.8% and trades around a 10% discount to NAV with a disciplined, resilient first‑lien loan book and low non‑accruals; together they provide immediate diversification and strong long‑term total return potential.
24/7 Wall St. spotlights five Dividend Kings that have raised dividends for at least 50 years—Automatic Data Processing (ADP), Coca-Cola (KO), Emerson Electric (EMR), Johnson & Johnson (JNJ), and Procter & Gamble (PG)—as top picks for safe, buy‑and‑hold income. Each carries a current yield around 1.5%–3%, and all five are rated Buy by major firms, underscoring their durable business models and long dividend‑growth track records in uncertain markets.
The piece highlights five dividend-oriented picks for income and defensiveness: PepsiCo (~3.5% yield) as a strong consumer-staples play; Pfizer (~6.3% forward yield) with a renewed pipeline and growth trajectory; Realty Income (REIT) with a ~5% yield and a monthly dividend backed by high occupancy; Verizon (~5.8% yield) for reliable income amid modest growth; and IBM (~2.6% yield) with a long dividend-raising streak and rising high-margin, recurring software/services revenue. The theme is income-focused, defensive exposure in a market wary of overvalued growth.
Five ultra-high-yield dividend stocks to buy in 2026: Enterprise Products Partners, Realty Income, Brookfield Infrastructure Partners, Oneok, and MPLX. The piece argues their roughly 5%–7.7% yields are supported by stable cash flows, growth through project execution or accretive acquisitions, long-term contracts, and potential dividend increases, making them appealing for income-focused investors in 2026.
Income investors can adopt a specific strategy recommended by Morningstar to enhance their investment performance by 2026, focusing on dividend-paying stocks and balanced portfolios.
Pfizer's dividend, with a high yield of 6.9%, is relatively safe despite a high payout ratio and upcoming patent expirations, supported by strong free cash flow and management's commitment, though some risks remain due to patent losses and earnings pressure.
The article discusses top income investment ideas for 2026, highlighting the potential of dividend stocks, energy pipelines, REITs, international equities, and fixed-income securities, amidst a cautiously optimistic outlook for yields and returns, with sector rankings and strategic insights for investors.
Wall Street is optimistic about a particular beaten-down dividend-paying stock's prospects for 2026, highlighting potential opportunities for income investors despite recent market challenges.
The article highlights five top dividend stocks favored by Wall Street analysts for their stability, growth potential, and reliable income, especially during volatile market conditions. These include Energy Transfer LP, Permian Resources, Smurfit Westrock, Netstreit, and Essential Properties Realty Trust, all rated as 'Strong Buy' with significant upside potential and attractive yields, making them suitable for income-focused investors heading into 2026.
The article highlights three top Dividend Kings—Procter & Gamble, Johnson & Johnson, and Emerson Electric—that offer reliable, long-term dividend growth, stable financials, and strong analyst ratings, making them ideal for income-focused investors seeking stability and potential for wealth accumulation.
The article discusses five stocks that are recommended for income investment in the second half of the year, highlighting the shift of financial advisors towards diversified and stable assets amid market uncertainty, including new ETFs from Vanguard targeting riskier bond market segments.
British American Tobacco, despite a declining cigarette market, offers a nearly 10% dividend yield and strong cash flows, making it an attractive option for income investors. The company is also investing in new nicotine products to sustain future growth.
British American Tobacco, despite a declining cigarette market, offers a nearly 10% dividend yield and strong cash flows, making it an attractive option for income investors. The company is countering declining cigarette volumes with price hikes and expanding into new nicotine products like e-vapor and nicotine pouches, which are showing significant growth and profitability. This positions British American Tobacco to sustain and potentially grow its dividend payments in the future.
The article highlights three dividend stocks with yields above 5%, including Pfizer, recommended for income-focused investors. The Motley Fool has positions in and recommends Pfizer, British American Tobacco, and Enterprise Products Partners.
The author discusses the importance of taking a holistic approach to evaluating investment portfolios, emphasizing the need to step back and consider the overall picture rather than fixating on individual holdings. They reveal that 50% of their retirement portfolio is invested in fixed-income securities and REITs, explaining the rationale behind these choices. They stress the significance of fixed-income investments for income investors and express optimism about the potential of REITs, particularly in light of anticipated interest rate decreases. The author advocates for a strategic approach to income investing and invites readers to join their community for access to their model portfolio and top picks.